Riccardo C Bonadonna Selected Research

Riccardo C Bonadonna Research Topics

Disease

31	Insulin Resistance 03/2022 - 02/2002
31	Type 2 Diabetes Mellitus (MODY) 03/2022 - 02/2002
7	Inflammation (Inflammations) 03/2022 - 06/2008
7	Glucose Intolerance 01/2021 - 09/2003
7	Obesity 01/2021 - 09/2003
6	Body Weight (Weight, Body) 01/2022 - 12/2012
5	Overweight 10/2019 - 07/2004
5	Cardiovascular Diseases (Cardiovascular Disease) 10/2018 - 05/2013
4	Chronic Renal Insufficiency 04/2021 - 05/2011
4	Hypertension (High Blood Pressure) 01/2020 - 07/2004
4	Prediabetic State (Prediabetes) 12/2018 - 09/2003
3	Weight Loss (Weight Reduction) 12/2018 - 03/2012
2	Insulinoma 01/2022 - 01/2022
2	Gastrinoma 01/2022 - 01/2022
2	Neoplasms (Cancer) 01/2022 - 01/2022
2	Albuminuria 05/2021 - 01/2020
2	Thrombosis (Thrombus) 01/2020 - 12/2018
2	Fibrosis (Cirrhosis) 01/2019 - 12/2015
2	Dyslipidemias (Dyslipidemia) 07/2017 - 07/2004
2	Atherosclerosis 06/2015 - 05/2013
2	Hyperinsulinism (Hyperinsulinemia) 11/2008 - 02/2002
2	Hyperglycemia 07/2004 - 02/2002
1	Disease Progression 03/2022
1	Necrosis 03/2022
1	Cystic Fibrosis (Mucoviscidosis) 01/2021
1	Atherosclerotic Plaque (Atheroma) 01/2020
1	Chronic Disease (Chronic Diseases) 10/2019
1	Abdominal Obesity 11/2017
1	Duodenitis 07/2017
1	Epstein-Barr Virus Infections 07/2017
1	Heart Failure 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2016
1	Diabetes Mellitus 12/2015
1	Genetic Risk Score 06/2015
1	Weight Gain 01/2014

Drug/Important Bio-Agent (IBA)

34	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 02/2003
30	Insulin (Novolin)FDA Link 03/2022 - 02/2002
10	LipidsIBA 01/2021 - 09/2003
6	C-PeptideIBA 03/2022 - 05/2011
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2016
5	Insulin Glargine (Lantus)FDA Link 01/2022 - 10/2017
5	Triglycerides (Triacylglycerol)IBA 05/2013 - 02/2007
4	C-Reactive ProteinIBA 12/2018 - 02/2007
4	HDL CholesterolIBA 07/2017 - 02/2007
3	AdiponectinIBA 03/2022 - 02/2007
3	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 01/2017
3	Oxidants (Oxidizing Agents)IBA 01/2022 - 02/2002
3	Metformin (Glucophage)FDA LinkGeneric 12/2018 - 01/2017
3	lixisenatideIBA 10/2017 - 01/2014
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2013 - 04/2011
2	empagliflozinIBA 01/2022 - 01/2020
2	stearic acid (magnesium stearate)FDA LinkGeneric 01/2022 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 04/2003
2	StearatesIBA 01/2020 - 12/2017
2	Liraglutide FDA Link 12/2018 - 11/2017
2	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2017 - 01/2014
2	oxidized low density lipoproteinIBA 04/2016 - 02/2007
2	CholesterolIBA 02/2008 - 04/2003
1	CytokinesIBA 03/2022
1	MyokinesIBA 03/2022
1	SodiumIBA 01/2022
1	Protons (Proton)IBA 01/2022
1	IsotopesIBA 10/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Adenosine Diphosphate (ADP)IBA 01/2020
1	Sodium-Glucose Transport ProteinsIBA 01/2020
1	dapagliflozinIBA 01/2020
1	Zinc Transporter 8IBA 11/2019
1	Vitamin D FDA LinkGeneric 10/2019
1	ThromboxanesIBA 12/2018
1	IsoprostanesIBA 12/2018
1	Glucagon-Like Peptide ReceptorsIBA 12/2018
1	IncretinsIBA 12/2018
1	CreatinineIBA 10/2018
1	AlbuminsIBA 10/2018
1	GlucuronidesIBA 12/2017
1	flavanoneIBA 12/2017
1	hesperetin-7-O-glucuronideIBA 12/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2017
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 11/2017
1	ChitosanIBA 07/2017
1	red yeast riceIBA 07/2017
1	Creatine Kinase (Creatine Phosphokinase)IBA 07/2017
1	BerberineIBA 07/2017
1	erucylphosphocholineIBA 01/2017
1	Glyburide (Glibenclamide)FDA LinkGeneric 01/2017
1	VildagliptinIBA 01/2017
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 11/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2016
1	Interleukin-6 (Interleukin 6)IBA 06/2016
1	Interleukin-10 (Interleukin 10)IBA 06/2016
1	Fenofibrate (CiL)FDA LinkGeneric 04/2016
1	CalciumIBA 06/2015
1	Short-Acting InsulinIBA 01/2014
1	Saline SolutionIBA 05/2013

Therapy/Procedure

8	Therapeutics 10/2019 - 01/2012
2	Bariatric Surgery 01/2021 - 01/2012
2	Glycemic Control 12/2018 - 11/2017
1	Transplantation 01/2019